1
|
da Silva Lopes K, Abe SK. Polymorphisms Contributing to Calcium Status: A Systematic Review. Nutrients 2021; 13:2488. [PMID: 34444650 PMCID: PMC8398213 DOI: 10.3390/nu13082488] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/28/2021] [Revised: 07/08/2021] [Accepted: 07/17/2021] [Indexed: 01/28/2023] Open
Abstract
This systematic review assessed genotypes and changes in calcium homeostasis. A literature search was performed in EMBASE, Medline and CENTRAL on 7 August 2020 identifying 1012 references. Studies were included with any human population related to the topic of interest, and genetic variations in genes related to calcium metabolism were considered. Two reviewers independently screened references, extracted relevant data and assessed study quality using the Q-Genie tool. Forty-one studies investigating Single Nucleotide Polymorphisms (SNPs) in relation to calcium status were identified. Almost half of the included studies were of good study quality according to the Q-Genie tool. Seventeen studies were cross-sectional, 14 case-control, seven association and three were Mendelian randomization studies. Included studies were conducted in over 18 countries. Participants were mainly adults, while six studies included children and adolescents. Ethnicity was described in 31 studies and half of these included Caucasian participants. Twenty-six independent studies examined the association between calcium and polymorphism in the calcium-sensing receptor (CASR) gene. Five studies assessed the association between polymorphisms of the Vitamin D receptor (VDR) gene and changes in calcium levels or renal excretion. The remaining ten studies investigated calcium homeostasis and other gene polymorphisms such as the CYP24A1 SNP or CLDN14. This study identified several CASR, VDR and other gene SNPs associated with calcium status. However, to provide evidence to guide dietary recommendations, further research is needed to explore the association between common polymorphisms and calcium requirements.
Collapse
Affiliation(s)
| | - Sarah Krull Abe
- Center for Public Health Sciences, National Cancer Center, Division of Prevention, Tokyo 104-0045, Japan
| |
Collapse
|
2
|
Stimulation of ORAI1 expression, store-operated Ca 2+ entry, and osteogenic signaling by high glucose exposure of human aortic smooth muscle cells. Pflugers Arch 2020; 472:1093-1102. [PMID: 32556706 DOI: 10.1007/s00424-020-02405-1] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/13/2019] [Revised: 04/24/2020] [Accepted: 05/22/2020] [Indexed: 12/23/2022]
Abstract
Diabetes and chronic kidney disease (CKD) both trigger vascular osteogenic signaling and calcification leading to early death by cardiovascular events. Osteogenic signaling involves upregulation of the transcription factors CBFA1, MSX2, and SOX9, as well as alkaline phosphatase (ALP), an enzyme fostering calcification by degrading the calcification inhibitor pyrophosphate. In CKD, osteogenic signaling is triggered by hyperphosphatemia, which upregulates the serum and glucocorticoid-inducible kinase SGK1, a strong stimulator of the Ca2+-channel ORAI1. The channel is activated by STIM1 and accomplishes store-operated Ca2+-entry (SOCE). The present study explored whether exposure of human aortic smooth muscle cells (HAoSMCs) to high extracellular glucose concentrations similarly upregulates ORAI1 and/or STIM1 expression, SOCE, and osteogenic signaling. To this end, HAoSMCs were exposed to high extracellular glucose concentrations (15 mM, 24 h) without or with additional exposure to the phosphate donor ß-glycerophosphate. Transcript levels were estimated using qRT-PCR, protein abundance using Western blotting, ALP activity using a colorimetric assay kit, calcium deposits utilizing Alizarin red staining, cytosolic Ca2+-concentration ([Ca2+]i) by Fura-2-fluorescence, and SOCE from increase of [Ca2+]i following re-addition of extracellular Ca2+ after store depletion with thapsigargin (1 μM). As a result, glucose enhanced the transcript levels of SGK1 and ORAI1, ORAI2, and STIM2, protein abundance of ORAI1, SOCE, the transcript levels of CBFA1, MSX2, SOX9, and ALPL, as well as calcium deposits. Moreover, glucose significantly augmented the stimulating effect of ß-glycerophosphate on transcript levels of SGK1 and ORAI1, SOCE, the transcript levels of osteogenic markers, as well as calcium deposits. ORAI1 inhibitor MRS1845 (10 μM) significantly blunted the glucose-induced upregulation of the CBFA1 and MSX2 transcript levels. In conclusion, the hyperglycemia of diabetes stimulates expression of SGK1 and ORAI1, thus, augmenting store-operated Ca2+-entry and osteogenic signaling in HAoSMCs.
Collapse
|
3
|
Pelzl L, Sahu I, Ma K, Heinzmann D, Bhuyan AAM, Al-Maghout T, Sukkar B, Sharma Y, Marini I, Rigoni F, Artunc F, Cao H, Gutti R, Voelkl J, Pieske B, Gawaz M, Bakchoul T, Lang F. Beta-Glycerophosphate-Induced ORAI1 Expression and Store Operated Ca 2+ Entry in Megakaryocytes. Sci Rep 2020; 10:1728. [PMID: 32015442 PMCID: PMC6997179 DOI: 10.1038/s41598-020-58384-x] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/15/2019] [Accepted: 01/03/2020] [Indexed: 12/13/2022] Open
Abstract
Impairment of renal phosphate elimination in chronic kidney disease (CKD) leads to enhanced plasma and tissue phosphate concentration, which in turn up-regulates transcription factor NFAT5 and serum & glucocorticoid-inducible kinase SGK1. The kinase upregulates ORAI1, a Ca2+-channel accomplishing store-operated Ca2+-entry (SOCE). ORAI1 is stimulated following intracellular store depletion by Ca2+-sensors STIM1 and/or STIM2. In megakaryocytes and blood platelets SOCE and thus ORAI1 are powerful regulators of activity. The present study explored whether the phosphate-donor ß-glycerophosphate augments NFAT5, ORAI1,2,3 and/or STIM1,2 expressions and thus SOCE in megakaryocytes. Human megakaryocytic Meg01cells were exposed to 2 mM of phosphate-donor ß-glycerophosphate for 24 hours. Platelets were isolated from blood samples of patients with impaired kidney function or control volunteers. Transcript levels were estimated utilizing q-RT-PCR, cytosolic Ca2+-concentration ([Ca2+]i) by Fura-2-fluorescence, and SOCE from increase of [Ca2+]i following re-addition of extracellular Ca2+ after store depletion with thapsigargin (1 µM). NFAT5 and ORAI1 protein abundance was estimated with Western blots. As a result, ß-glycerophosphate increased NFAT5, ORAI1/2/3, STIM1/2 transcript levels, as well as SOCE. Transcript levels of NFAT5, SGK1, ORAI1/2/3, and STIM1/2 as well as NFAT5 and ORAI1 protein abundance were significantly higher in platelets isolated from patients with impaired kidney function than in platelets from control volunteers. In conclusion, phosphate-donor ß-glycerophosphate triggers a signaling cascade of NFAT5/SGK1/ORAI/STIM, thus up-regulating store-operated Ca2+-entry.
Collapse
Affiliation(s)
- Lisann Pelzl
- Transfusion Medicine, Medical Faculty, Eberhard Karl University Tuebingen, Tuebingen, Germany
| | - Itishri Sahu
- Department of Internal Medicine III, Eberhard Karl University Tuebingen, Tuebingen, Germany.,Department of Biochemistry, School of Life Sciences, University of Hyderabad, Hyderabad, 500046, India
| | - Ke Ma
- Department of Internal Medicine III, Eberhard Karl University Tuebingen, Tuebingen, Germany
| | - David Heinzmann
- Department of Internal Medicine III, Eberhard Karl University Tuebingen, Tuebingen, Germany
| | | | - Tamer Al-Maghout
- Department of Internal Medicine III, Eberhard Karl University Tuebingen, Tuebingen, Germany
| | - Basma Sukkar
- Department of Internal Medicine III, Eberhard Karl University Tuebingen, Tuebingen, Germany
| | - Yamini Sharma
- Department of Internal Medicine III, Eberhard Karl University Tuebingen, Tuebingen, Germany
| | - Irene Marini
- Transfusion Medicine, Medical Faculty, Eberhard Karl University Tuebingen, Tuebingen, Germany
| | - Flaviana Rigoni
- Transfusion Medicine, Medical Faculty, Eberhard Karl University Tuebingen, Tuebingen, Germany
| | - Ferruh Artunc
- Department of Internal Medicine IV, Eberhard Karl University Tuebingen, Tuebingen, Germany
| | - Hang Cao
- Department of Internal Medicine III, Eberhard Karl University Tuebingen, Tuebingen, Germany
| | - Ravi Gutti
- Department of Biochemistry, School of Life Sciences, University of Hyderabad, Hyderabad, 500046, India
| | - Jakob Voelkl
- Institute for Physiology, Johannes Kepler University, Linz, Austria.,DZHK (German Centre for Cardiovascular Research), partner site Berlin, Berlin, Germany.,Department of Nephrology and Medical Intensive Care, Charité University Medicine, Berlin, Germany.,Department of Internal Medicine and Cardiology, Campus Virchow Klinikum, Charité University Medicine, Berlin, Germany
| | - Burkert Pieske
- DZHK (German Centre for Cardiovascular Research), partner site Berlin, Berlin, Germany.,Berlin Institute of Health (BIH), Berlin, and Department of Internal Medicine and Cardiology, German Heart Center Berlin (DHZB), Berlin, Germany.,Department of Internal Medicine and Cardiology, Campus Virchow Klinikum, Charité University Medicine, Berlin, Germany
| | - Meinrad Gawaz
- Department of Internal Medicine III, Eberhard Karl University Tuebingen, Tuebingen, Germany
| | - Tamam Bakchoul
- Transfusion Medicine, Medical Faculty, Eberhard Karl University Tuebingen, Tuebingen, Germany.,Centre for Clinical Transfusion Medicine, University Hospital of Tuebingen, Tuebingen, Germany
| | - Florian Lang
- Department of Vegetative and Clinical Physiology, Eberhard Karl University Tuebingen, Tuebingen, Germany.
| |
Collapse
|
4
|
Ma K, Liu P, Al-Maghout T, Sukkar B, Cao H, Voelkl J, Alesutan I, Pieske B, Lang F. Phosphate-induced ORAI1 expression and store-operated Ca 2+ entry in aortic smooth muscle cells. J Mol Med (Berl) 2019; 97:1465-1475. [PMID: 31385016 DOI: 10.1007/s00109-019-01824-7] [Citation(s) in RCA: 16] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/12/2019] [Revised: 07/02/2019] [Accepted: 07/25/2019] [Indexed: 12/16/2022]
Abstract
Compromised renal phosphate elimination in chronic kidney disease (CKD) leads to hyperphosphatemia, which in turn triggers osteo-/chondrogenic signaling in vascular smooth muscle cells (VSMCs) and vascular calcification. Osteo-/chondrogenic transdifferentiation of VSMCs leads to upregulation of the transcription factors MSX2, CBFA1, and SOX9 as well as tissue-nonspecific alkaline phosphatase (ALPL) which fosters calcification by degrading the calcification inhibitor pyrophosphate. Osteo-/chondrogenic signaling in VSMCs involves the serum- and glucocorticoid-inducible kinase SGK1. As shown in other cell types, SGK1 is a powerful stimulator of ORAI1, a Ca2+-channel accomplishing store-operated Ca2+-entry (SOCE). ORAI1 is stimulated following intracellular store depletion by the Ca2+ sensor STIM1. The present study explored whether phosphate regulates ORAI1 and/or STIM1 expression and, thus, SOCE in VSMCs. To this end, primary human aortic smooth muscle cells (HAoSMCs) were exposed to the phosphate donor β-glycerophosphate. Transcript levels were estimated by qRT-PCR, protein abundance by western blotting, ALPL activity by colorimetry, calcification by alizarin red S staining, cytosolic Ca2+-concentration ([Ca2+]i) by Fura-2-fluorescence, and SOCE from increase of [Ca2+]i following re-addition of extracellular Ca2+ after store depletion with thapsigargin. As a result, β-glycerophosphate treatment increased ORAI1 and STIM1 transcript levels and protein abundance as well as SOCE in HAoSMCs. Additional treatment with ORAI1 inhibitor MRS1845 or SGK1 inhibitor GSK650394 virtually disrupted the effects of β-glycerophosphate on SOCE. Moreover, the β-glycerophosphate-induced MSX2, CBFA1, SOX9, and ALPL mRNA expression and activity in HAoSMCs were suppressed in the presence of the ORAI1 inhibitor and upon ORAI1 silencing. In conclusion, enhanced phosphate upregulates ORAI1 and STIM1 expression and store-operated Ca2+-entry, which participate in the orchestration of osteo-/chondrogenic signaling of VSMCs. KEY MESSAGES: • In aortic SMC, phosphate donor ß-glycerophosphate upregulates Ca2+ channel ORAI1. • In aortic SMC, ß-glycerophosphate upregulates ORAI1-activator STIM1. • In aortic SMC, ß-glycerophosphate upregulates store-operated Ca2+-entry (SOCE). • The effect of ß-glycerophosphate on SOCE is disrupted by ORAI1 inhibitor MRS1845. • Stimulation of osteogenic signaling is disrupted by MRS1845 and ORAI1 silencing.
Collapse
Affiliation(s)
- Ke Ma
- Department of Pharmacology & Experimental Therapy, University of Tübingen, 72076, Tübingen, Germany
| | - Ping Liu
- Department of Pharmacology & Experimental Therapy, University of Tübingen, 72076, Tübingen, Germany
| | - Tamer Al-Maghout
- Department of Pharmacology & Experimental Therapy, University of Tübingen, 72076, Tübingen, Germany
| | - Basma Sukkar
- Department of Pharmacology & Experimental Therapy, University of Tübingen, 72076, Tübingen, Germany
| | - Hang Cao
- Department of Pharmacology & Experimental Therapy, University of Tübingen, 72076, Tübingen, Germany
| | - Jakob Voelkl
- Institute for Physiology and Pathophysiology, Johannes Kepler University Linz, 4040, Linz, Austria.,Department of Internal Medicine and Cardiology, Charité University Medicine, Campus Virchow-Klinikum, Berlin, Germany.,DZHK (German Centre for Cardiovascular Research), Partner Site, Berlin, Germany.,Department of Nephrology and Medical Intensive Care, Charité University Medicine, Berlin, Germany
| | - Ioana Alesutan
- Institute for Physiology and Pathophysiology, Johannes Kepler University Linz, 4040, Linz, Austria.,Department of Internal Medicine and Cardiology, Charité University Medicine, Campus Virchow-Klinikum, Berlin, Germany.,DZHK (German Centre for Cardiovascular Research), Partner Site, Berlin, Germany.,Berlin Institute of Health (BIH), Berlin, Germany
| | - Burkert Pieske
- Department of Internal Medicine and Cardiology, Charité University Medicine, Campus Virchow-Klinikum, Berlin, Germany.,DZHK (German Centre for Cardiovascular Research), Partner Site, Berlin, Germany.,Berlin Institute of Health (BIH), Berlin, Germany.,Department of Internal Medicine and Cardiology, German Heart Center Berlin (DHZB), Berlin, Germany
| | - Florian Lang
- Department of Vegetative and Clinical Physiology, University of Tübingen, Wilhelmstr. 56, 72074, Tübingen, Germany.
| |
Collapse
|
5
|
Jahan I, Ahmed S, Islam MR, Hai ANMA, Islam MF, Bhuiyan MA, Nahar Z. Association of ORAI1 Genetic Polymorphism with Serum Calcium and Phosphorus Levels in Non-dialysis Chronic Kidney Disease Patients: A Case-control Study. Cureus 2019; 11:e4564. [PMID: 31281748 PMCID: PMC6599462 DOI: 10.7759/cureus.4564] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022] Open
Abstract
Background As chronic kidney disease (CKD) is a silent killer, it is now a global concern to find out the possible causes by genetic and biological markers. In the earlier stages of CKD, serum calcium and phosphorus levels fall down later on turned into hypercalcemia and hyperphosphatemia contributing high mortality in CKD. This study aimed to examine the serum calcium and phosphorus levels in non-dialysis CKD patients and healthy controls to find out their association with ORAI1 genetic polymorphism. Methods The present study recruited 96 non-dialysis CKD patients and 100 control subjects matched by age, gender, and body mass index (BMI). Measurement of serum calcium levels was performed with atomic absorption spectrophotometer (HITACHI, 170-30) and phosphorus levels were determined by UV VIS spectrophotometer (Analytik Jena SPEKOL 2000). PCR-RFLP technique was applied to determine the genetic polymorphism of ORAI1 (rs12313273 and rs6486795) gene. Results The mean values of serum calcium and phosphorus levels were 2.53 ± 0.50 mg/dL and 3.77 ± 0.42 mg/dL for the patient group and 3.67 ± 2.37 mg/dL and 13.66 ± 6.34 mg/dL for the control group, respectively. We observed significantly reduced serum calcium and phosphorus levels in non-dialysis CKD patients compared with control subjects (p < 0.001). No significant polymorphism of ORAI1 (rs12313273 and rs6486795) was found with declined serum calcium and phosphorus levels. Conclusions The present study suggested that there is no linear correlation between ORAI1 genetic polymorphism with serum calcium and phosphorus levels in non-dialysis CKD patients.
Collapse
Affiliation(s)
- Ishrat Jahan
- Pharmacy, University of Asia Pacific, Dhaka, BGD
| | - Salma Ahmed
- Pharmacy, University of Asia Pacific, Dhaka, BGD
| | | | | | | | | | - Zabun Nahar
- Pharmacy, University of Asia Pacific, Dhaka, BGD
| |
Collapse
|
6
|
Blair HC, Soboloff J, Robinson LJ, Tourkova IL, Larrouture QC, Witt MR, Holaskova I, Schafer R, Elliott M, Hirsch R, Barnett JB. Suppression of arthritis-induced bone erosion by a CRAC channel antagonist. RMD Open 2016; 2:e000093. [PMID: 26819750 PMCID: PMC4716559 DOI: 10.1136/rmdopen-2015-000093] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/03/2015] [Revised: 11/10/2015] [Accepted: 12/10/2015] [Indexed: 12/22/2022] Open
Abstract
Objective We have shown in vitro and in vivo that osteoclast maturation requires calcium-release activated calcium (CRAC) channels. In inflammatory arthritis, osteoclasts mediate severe and debilitating bone erosion. In the current study, we assess the value of CRAC channels as a therapeutic target to suppress bone erosion in acute inflammatory arthritis. Methods Collagen-induced arthritis (CIA) was induced in mice. The CRAC channel inhibitor 3,4-dichloropropionaniline (DCPA) and a placebo was administered 1 day prior to collagen II booster to induce arthritis. Effects on swelling, inflammatory cell invasion in joints, serum cytokines and bone erosion were measured. Results Assays, by blinded observers, of arthritis severity showed that DCPA, 21 mg/kg/day, suppressed arthritis development over 3 weeks. Bone and cartilage damage in sections of animal feet was reduced approximately 50%; overall swelling of joints was reduced by a similar amount. Effects on bone density by µCT showed clear separation in DCPA-treated CIA animals from CIA without treatment, while differences between controls without CIA and CIA treated with DCPA differed by small amounts and in most cases were not statistically different. Response was not related to anticollagen titres. There were no adverse effects in the treated group on animal weight or activity, consistent with low toxicity. The effect was maximal 12–17 days after collagen booster, during the rapid appearance of arthritis in untreated CIA. At 20 days after treatment (day 40), differences in arthritis score were reduced and tumour necrosis factor α, interleukin (IL)-1, or IL-6 in the serum of the animals were similar in treated and untreated animals. Conclusions DCPA, a novel inhibitor of CRAC channels, suppresses bone erosion associated with acute arthritis in mice and might represent a new treatment modality for acute arthrits.
Collapse
Affiliation(s)
- Harry C Blair
- Departments of Pathology and of Cell Biology , The Pittsburgh VA Medical Center and the University of Pittsburgh , Pittsburgh , USA
| | - Jonathan Soboloff
- Fels Institute for Cancer Research and Molecular Biology and the Department of Medical Genetics & Molecular Biochemistry , Temple University School of Medicine , Philadelphia, Pennsylvania , USA
| | - Lisa J Robinson
- Departments of Pathology and of Microbiology, Immunology & Cell Biology , West Virginia University School of Medicine , Morgantown, West Virginia , USA
| | - Irina L Tourkova
- Departments of Pathology and of Cell Biology , The Pittsburgh VA Medical Center and the University of Pittsburgh , Pittsburgh , USA
| | - Quitterie C Larrouture
- Departments of Pathology and of Cell Biology , The Pittsburgh VA Medical Center and the University of Pittsburgh , Pittsburgh , USA
| | - Michelle R Witt
- Departments of Pathology and of Cell Biology , The Pittsburgh VA Medical Center and the University of Pittsburgh , Pittsburgh , USA
| | - Ida Holaskova
- Department of Microbiology, Immunology & Cell Biology, and the Mary Babb Randolph Cancer Center , West Virginia University School of Medicine , Morgantown, West Virginia , USA
| | - Rosana Schafer
- Department of Microbiology, Immunology & Cell Biology, and the Mary Babb Randolph Cancer Center , West Virginia University School of Medicine , Morgantown, West Virginia , USA
| | - Meenal Elliott
- Department of Microbiology, Immunology & Cell Biology, and the Mary Babb Randolph Cancer Center , West Virginia University School of Medicine , Morgantown, West Virginia , USA
| | - Raphael Hirsch
- Department of Pediatrics , University of Iowa Carver College of Medicine , Iowa City ,
| | - John B Barnett
- Department of Microbiology, Immunology & Cell Biology, and the Mary Babb Randolph Cancer Center , West Virginia University School of Medicine , Morgantown, West Virginia , USA
| |
Collapse
|
7
|
Miao L, Wei D, Zhang Y, Liu J, Lu S, Zhang A, Huang S. Effects of stromal interaction molecule 1 or Orai1 overexpression on the associated proteins and permeability of podocytes. Nephrology (Carlton) 2015; 21:959-967. [PMID: 26715123 DOI: 10.1111/nep.12691] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/04/2015] [Revised: 11/21/2015] [Accepted: 11/27/2015] [Indexed: 10/22/2022]
Abstract
AIM The present study was conducted to determine whether two important signalling molecules of store-operated channel (SOC), stromal interaction molecule 1 (STIM1) and Orai1, were involved in glomerular podocyte injury. We explored the effects of STIM1/Orai1 overexpression on podocyte associated proteins and cell permeability. METHODS The expression of STIM1 and Orai1 were examined in the renal cortex of adriamycin-induced nephropathy mice by real-time RT-PCR. The recombinant plasmid of STIM1/Orai1, identified by restriction enzyme digestion and PCR, was transfected into MPC5 cells via lipofectamine 2000. The transfecting efficiency was observed by a fluorescence microscope. RT-PCR and Western blotting were used to evaluate the expression levels of STIM1, Orai 1 and some podocyte-associated molecules in the transfected MPC5 cells. In addition, we examined the diffusion of FITC-dextran across the podocyte monolayer to investigate whether STIM1/Orai1 overexpression could affect cell permeability. RESULTS We found that the mRNA levels of STIM1 and Orai1 were increased in adriamycin-induced nephropathy mice. STIM1/Orai1 overexpression significantly decreased the expression of podocin and CD2-associated protein (CD2AP), whereas it increased the expression of α-actinin-4. The permeability was significantly increased in the STIM1/Orai1 overexpression group. CONCLUSION Our findings suggested that STIM1/Orai1 overexpression could affect the cell permeability and the expression of partial podocyte-associated proteins, which may ultimately result in podocyte injury.
Collapse
Affiliation(s)
- Li Miao
- Nanjing Children's Hospital Affiliated to Nanjing Medical University, Nanjing, China.,Lianyungang Clinical School of Nanjing Medical University, Lianyungang, China
| | - Dongyue Wei
- Lianyungang Clinical School of Nanjing Medical University, Lianyungang, China
| | - Yuanyuan Zhang
- Nanjing Children's Hospital Affiliated to Nanjing Medical University, Nanjing, China
| | - Jiansheng Liu
- Lianyungang Clinical School of Nanjing Medical University, Lianyungang, China
| | - Siguang Lu
- Lianyungang Clinical School of Nanjing Medical University, Lianyungang, China
| | - Aihua Zhang
- Nanjing Children's Hospital Affiliated to Nanjing Medical University, Nanjing, China
| | - Songming Huang
- Nanjing Children's Hospital Affiliated to Nanjing Medical University, Nanjing, China.
| |
Collapse
|